0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Infliximab Injection Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-25P17398
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Infliximab Injection Market Research Report 2024
BUY CHAPTERS

Global Infliximab Injection Market Research Report 2024

Code: QYRE-Auto-25P17398
Report
June 2024
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Infliximab Injection Market

Infliximab injection is an antibody drug composed of chimeric monoclonal antibodies. It reduces inflammatory responses by inhibiting the activity of TNF-α and is used to treat a variety of chronic inflammatory diseases.
The global Infliximab Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Infliximab Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Infliximab Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Infliximab Injection include Celltrion, Janssen Biologics, Hangzhou Bozhirui Biopharmaceuticals, Taizhou Maiboteike Pharmaceuticals, Yuxi Jiahe Biotechnology, Ayumi Pharmaceuticals, Pfizer, Nichiiko, Nippon Kayaku, AMGEN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Infliximab Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infliximab Injection.
The Infliximab Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Infliximab Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infliximab Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Infliximab Injection Market Report

Report Metric Details
Report Name Infliximab Injection Market
Segment by Type
  • Original Drug
  • Generic Drug
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Celltrion, Janssen Biologics, Hangzhou Bozhirui Biopharmaceuticals, Taizhou Maiboteike Pharmaceuticals, Yuxi Jiahe Biotechnology, Ayumi Pharmaceuticals, Pfizer, Nichiiko, Nippon Kayaku, AMGEN
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Infliximab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Infliximab Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Infliximab Injection Market report?

Ans: The main players in the Infliximab Injection Market are Celltrion, Janssen Biologics, Hangzhou Bozhirui Biopharmaceuticals, Taizhou Maiboteike Pharmaceuticals, Yuxi Jiahe Biotechnology, Ayumi Pharmaceuticals, Pfizer, Nichiiko, Nippon Kayaku, AMGEN

What are the Application segmentation covered in the Infliximab Injection Market report?

Ans: The Applications covered in the Infliximab Injection Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Infliximab Injection Market report?

Ans: The Types covered in the Infliximab Injection Market report are Original Drug, Generic Drug

1 Infliximab Injection Market Overview
1.1 Product Definition
1.2 Infliximab Injection by Type
1.2.1 Global Infliximab Injection Market Value Comparison by Type (2024-2030)
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Infliximab Injection by Application
1.3.1 Global Infliximab Injection Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Infliximab Injection Market Size Estimates and Forecasts
1.4.1 Global Infliximab Injection Revenue 2019-2030
1.4.2 Global Infliximab Injection Sales 2019-2030
1.4.3 Global Infliximab Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Infliximab Injection Market Competition by Manufacturers
2.1 Global Infliximab Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Infliximab Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Infliximab Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Infliximab Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Infliximab Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Infliximab Injection, Product Type & Application
2.7 Global Key Manufacturers of Infliximab Injection, Date of Enter into This Industry
2.8 Global Infliximab Injection Market Competitive Situation and Trends
2.8.1 Global Infliximab Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Infliximab Injection Players Market Share by Revenue
2.8.3 Global Infliximab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Infliximab Injection Market Scenario by Region
3.1 Global Infliximab Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Infliximab Injection Sales by Region: 2019-2030
3.2.1 Global Infliximab Injection Sales by Region: 2019-2024
3.2.2 Global Infliximab Injection Sales by Region: 2025-2030
3.3 Global Infliximab Injection Revenue by Region: 2019-2030
3.3.1 Global Infliximab Injection Revenue by Region: 2019-2024
3.3.2 Global Infliximab Injection Revenue by Region: 2025-2030
3.4 North America Infliximab Injection Market Facts & Figures by Country
3.4.1 North America Infliximab Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Infliximab Injection Sales by Country (2019-2030)
3.4.3 North America Infliximab Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Infliximab Injection Market Facts & Figures by Country
3.5.1 Europe Infliximab Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Infliximab Injection Sales by Country (2019-2030)
3.5.3 Europe Infliximab Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Infliximab Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Infliximab Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Infliximab Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Infliximab Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Infliximab Injection Market Facts & Figures by Country
3.7.1 Latin America Infliximab Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Infliximab Injection Sales by Country (2019-2030)
3.7.3 Latin America Infliximab Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Infliximab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Infliximab Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Infliximab Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Infliximab Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Infliximab Injection Sales by Type (2019-2030)
4.1.1 Global Infliximab Injection Sales by Type (2019-2024)
4.1.2 Global Infliximab Injection Sales by Type (2025-2030)
4.1.3 Global Infliximab Injection Sales Market Share by Type (2019-2030)
4.2 Global Infliximab Injection Revenue by Type (2019-2030)
4.2.1 Global Infliximab Injection Revenue by Type (2019-2024)
4.2.2 Global Infliximab Injection Revenue by Type (2025-2030)
4.2.3 Global Infliximab Injection Revenue Market Share by Type (2019-2030)
4.3 Global Infliximab Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Infliximab Injection Sales by Application (2019-2030)
5.1.1 Global Infliximab Injection Sales by Application (2019-2024)
5.1.2 Global Infliximab Injection Sales by Application (2025-2030)
5.1.3 Global Infliximab Injection Sales Market Share by Application (2019-2030)
5.2 Global Infliximab Injection Revenue by Application (2019-2030)
5.2.1 Global Infliximab Injection Revenue by Application (2019-2024)
5.2.2 Global Infliximab Injection Revenue by Application (2025-2030)
5.2.3 Global Infliximab Injection Revenue Market Share by Application (2019-2030)
5.3 Global Infliximab Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Celltrion
6.1.1 Celltrion Company Information
6.1.2 Celltrion Description and Business Overview
6.1.3 Celltrion Infliximab Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Celltrion Infliximab Injection Product Portfolio
6.1.5 Celltrion Recent Developments/Updates
6.2 Janssen Biologics
6.2.1 Janssen Biologics Company Information
6.2.2 Janssen Biologics Description and Business Overview
6.2.3 Janssen Biologics Infliximab Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Janssen Biologics Infliximab Injection Product Portfolio
6.2.5 Janssen Biologics Recent Developments/Updates
6.3 Hangzhou Bozhirui Biopharmaceuticals
6.3.1 Hangzhou Bozhirui Biopharmaceuticals Company Information
6.3.2 Hangzhou Bozhirui Biopharmaceuticals Description and Business Overview
6.3.3 Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Product Portfolio
6.3.5 Hangzhou Bozhirui Biopharmaceuticals Recent Developments/Updates
6.4 Taizhou Maiboteike Pharmaceuticals
6.4.1 Taizhou Maiboteike Pharmaceuticals Company Information
6.4.2 Taizhou Maiboteike Pharmaceuticals Description and Business Overview
6.4.3 Taizhou Maiboteike Pharmaceuticals Infliximab Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Taizhou Maiboteike Pharmaceuticals Infliximab Injection Product Portfolio
6.4.5 Taizhou Maiboteike Pharmaceuticals Recent Developments/Updates
6.5 Yuxi Jiahe Biotechnology
6.5.1 Yuxi Jiahe Biotechnology Company Information
6.5.2 Yuxi Jiahe Biotechnology Description and Business Overview
6.5.3 Yuxi Jiahe Biotechnology Infliximab Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Yuxi Jiahe Biotechnology Infliximab Injection Product Portfolio
6.5.5 Yuxi Jiahe Biotechnology Recent Developments/Updates
6.6 Ayumi Pharmaceuticals
6.6.1 Ayumi Pharmaceuticals Company Information
6.6.2 Ayumi Pharmaceuticals Description and Business Overview
6.6.3 Ayumi Pharmaceuticals Infliximab Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ayumi Pharmaceuticals Infliximab Injection Product Portfolio
6.6.5 Ayumi Pharmaceuticals Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Infliximab Injection Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Pfizer Infliximab Injection Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Nichiiko
6.8.1 Nichiiko Company Information
6.8.2 Nichiiko Description and Business Overview
6.8.3 Nichiiko Infliximab Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Nichiiko Infliximab Injection Product Portfolio
6.8.5 Nichiiko Recent Developments/Updates
6.9 Nippon Kayaku
6.9.1 Nippon Kayaku Company Information
6.9.2 Nippon Kayaku Description and Business Overview
6.9.3 Nippon Kayaku Infliximab Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Nippon Kayaku Infliximab Injection Product Portfolio
6.9.5 Nippon Kayaku Recent Developments/Updates
6.10 AMGEN
6.10.1 AMGEN Company Information
6.10.2 AMGEN Description and Business Overview
6.10.3 AMGEN Infliximab Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 AMGEN Infliximab Injection Product Portfolio
6.10.5 AMGEN Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Infliximab Injection Industry Chain Analysis
7.2 Infliximab Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Infliximab Injection Production Mode & Process
7.4 Infliximab Injection Sales and Marketing
7.4.1 Infliximab Injection Sales Channels
7.4.2 Infliximab Injection Distributors
7.5 Infliximab Injection Customers
8 Infliximab Injection Market Dynamics
8.1 Infliximab Injection Industry Trends
8.2 Infliximab Injection Market Drivers
8.3 Infliximab Injection Market Challenges
8.4 Infliximab Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Infliximab Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Infliximab Injection Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Infliximab Injection Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Infliximab Injection Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Infliximab Injection Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Infliximab Injection Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Infliximab Injection Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Infliximab Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Infliximab Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Infliximab Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Infliximab Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Infliximab Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Infliximab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infliximab Injection as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Infliximab Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Infliximab Injection Sales by Region (2019-2024) & (K Units)
 Table 18. Global Infliximab Injection Sales Market Share by Region (2019-2024)
 Table 19. Global Infliximab Injection Sales by Region (2025-2030) & (K Units)
 Table 20. Global Infliximab Injection Sales Market Share by Region (2025-2030)
 Table 21. Global Infliximab Injection Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Infliximab Injection Revenue Market Share by Region (2019-2024)
 Table 23. Global Infliximab Injection Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Infliximab Injection Revenue Market Share by Region (2025-2030)
 Table 25. North America Infliximab Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Infliximab Injection Sales by Country (2019-2024) & (K Units)
 Table 27. North America Infliximab Injection Sales by Country (2025-2030) & (K Units)
 Table 28. North America Infliximab Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Infliximab Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Infliximab Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Infliximab Injection Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Infliximab Injection Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Infliximab Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Infliximab Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Infliximab Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Infliximab Injection Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Infliximab Injection Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Infliximab Injection Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Infliximab Injection Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Infliximab Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Infliximab Injection Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Infliximab Injection Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Infliximab Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Infliximab Injection Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Infliximab Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Infliximab Injection Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Infliximab Injection Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Infliximab Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Infliximab Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Infliximab Injection Sales (K Units) by Type (2019-2024)
 Table 51. Global Infliximab Injection Sales (K Units) by Type (2025-2030)
 Table 52. Global Infliximab Injection Sales Market Share by Type (2019-2024)
 Table 53. Global Infliximab Injection Sales Market Share by Type (2025-2030)
 Table 54. Global Infliximab Injection Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Infliximab Injection Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Infliximab Injection Revenue Market Share by Type (2019-2024)
 Table 57. Global Infliximab Injection Revenue Market Share by Type (2025-2030)
 Table 58. Global Infliximab Injection Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Infliximab Injection Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Infliximab Injection Sales (K Units) by Application (2019-2024)
 Table 61. Global Infliximab Injection Sales (K Units) by Application (2025-2030)
 Table 62. Global Infliximab Injection Sales Market Share by Application (2019-2024)
 Table 63. Global Infliximab Injection Sales Market Share by Application (2025-2030)
 Table 64. Global Infliximab Injection Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Infliximab Injection Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Infliximab Injection Revenue Market Share by Application (2019-2024)
 Table 67. Global Infliximab Injection Revenue Market Share by Application (2025-2030)
 Table 68. Global Infliximab Injection Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Infliximab Injection Price (US$/Unit) by Application (2025-2030)
 Table 70. Celltrion Company Information
 Table 71. Celltrion Description and Business Overview
 Table 72. Celltrion Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Celltrion Infliximab Injection Product
 Table 74. Celltrion Recent Developments/Updates
 Table 75. Janssen Biologics Company Information
 Table 76. Janssen Biologics Description and Business Overview
 Table 77. Janssen Biologics Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Janssen Biologics Infliximab Injection Product
 Table 79. Janssen Biologics Recent Developments/Updates
 Table 80. Hangzhou Bozhirui Biopharmaceuticals Company Information
 Table 81. Hangzhou Bozhirui Biopharmaceuticals Description and Business Overview
 Table 82. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Product
 Table 84. Hangzhou Bozhirui Biopharmaceuticals Recent Developments/Updates
 Table 85. Taizhou Maiboteike Pharmaceuticals Company Information
 Table 86. Taizhou Maiboteike Pharmaceuticals Description and Business Overview
 Table 87. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Product
 Table 89. Taizhou Maiboteike Pharmaceuticals Recent Developments/Updates
 Table 90. Yuxi Jiahe Biotechnology Company Information
 Table 91. Yuxi Jiahe Biotechnology Description and Business Overview
 Table 92. Yuxi Jiahe Biotechnology Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Yuxi Jiahe Biotechnology Infliximab Injection Product
 Table 94. Yuxi Jiahe Biotechnology Recent Developments/Updates
 Table 95. Ayumi Pharmaceuticals Company Information
 Table 96. Ayumi Pharmaceuticals Description and Business Overview
 Table 97. Ayumi Pharmaceuticals Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Ayumi Pharmaceuticals Infliximab Injection Product
 Table 99. Ayumi Pharmaceuticals Recent Developments/Updates
 Table 100. Pfizer Company Information
 Table 101. Pfizer Description and Business Overview
 Table 102. Pfizer Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Pfizer Infliximab Injection Product
 Table 104. Pfizer Recent Developments/Updates
 Table 105. Nichiiko Company Information
 Table 106. Nichiiko Description and Business Overview
 Table 107. Nichiiko Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Nichiiko Infliximab Injection Product
 Table 109. Nichiiko Recent Developments/Updates
 Table 110. Nippon Kayaku Company Information
 Table 111. Nippon Kayaku Description and Business Overview
 Table 112. Nippon Kayaku Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Nippon Kayaku Infliximab Injection Product
 Table 114. Nippon Kayaku Recent Developments/Updates
 Table 115. AMGEN Company Information
 Table 116. AMGEN Description and Business Overview
 Table 117. AMGEN Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. AMGEN Infliximab Injection Product
 Table 119. AMGEN Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Infliximab Injection Distributors List
 Table 123. Infliximab Injection Customers List
 Table 124. Infliximab Injection Market Trends
 Table 125. Infliximab Injection Market Drivers
 Table 126. Infliximab Injection Market Challenges
 Table 127. Infliximab Injection Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Infliximab Injection
 Figure 2. Global Infliximab Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Infliximab Injection Market Share by Type: 2023 & 2030
 Figure 4. Original Drug Product Picture
 Figure 5. Generic Drug Product Picture
 Figure 6. Global Infliximab Injection Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Infliximab Injection Market Share by Application: 2023 & 2030
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global Infliximab Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Infliximab Injection Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Infliximab Injection Sales (2019-2030) & (K Units)
 Figure 14. Global Infliximab Injection Average Price (US$/Unit) & (2019-2030)
 Figure 15. Infliximab Injection Report Years Considered
 Figure 16. Infliximab Injection Sales Share by Manufacturers in 2023
 Figure 17. Global Infliximab Injection Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Infliximab Injection Players: Market Share by Revenue in Infliximab Injection in 2023
 Figure 19. Infliximab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Infliximab Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Infliximab Injection Sales Market Share by Country (2019-2030)
 Figure 22. North America Infliximab Injection Revenue Market Share by Country (2019-2030)
 Figure 23. United States Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Infliximab Injection Sales Market Share by Country (2019-2030)
 Figure 26. Europe Infliximab Injection Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Infliximab Injection Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Infliximab Injection Revenue Market Share by Region (2019-2030)
 Figure 34. China Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Infliximab Injection Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Infliximab Injection Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Infliximab Injection Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Infliximab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Infliximab Injection by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Infliximab Injection by Type (2019-2030)
 Figure 53. Global Infliximab Injection Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Infliximab Injection by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Infliximab Injection by Application (2019-2030)
 Figure 56. Global Infliximab Injection Price (US$/Unit) by Application (2019-2030)
 Figure 57. Infliximab Injection Value Chain
 Figure 58. Infliximab Injection Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS